Ok to use weighted CRPs for Cost of equity?

Got a rather tough one for all of you modeling wizards and deep dive guys. I'm building a DCF for a company at its scale up stage. Growth is around 100% YoY, and EBITDA will soon become positive. Company currently operates in an EM and is looking to raise funds. As soon as they raise the said funds, most likely in a convertible loan, they will move forward with an EU - Germany - expansion. They have a proven business model and international growth assumptions are on rather solid grounds. 

Their revenue mix will shift to EU faster than their operations command due to massive exchange rate difference between home country and EU. This is obivously very good for them on many levels, and especially from a valuation perspective. EU revenues will not only command higher market multiple but also bring their cost of equity down for DCF. 

For the cost of equity, is it ok to intially start with a Local CAPM for home country and in the coming years shift to a weighted average -determined by revenue %- of German and home country risk premium in our CAPM? Will this be deemed too speculative by the investors as, frankly the company hasn't raised the funds, expanded in to the EU and made money there yet, and we are assigning cost of equity based on speculative forecasts? Being the hypergrowth company it is, the ERP we can assign today on future dates will make a MASSIVE difference in valuation, and I would assume investors would have some understanding of this. But just how much of this is acceptable practice? 

Note: Looking to fundraise in Euros

1 Comments
 

Dignissimos dolores nobis molestiae ea minima molestiae aut quam. Nulla officiis occaecati officia nisi quia repellat et ex. Eveniet atque debitis voluptate eligendi quam eos. Corporis qui quos consectetur quasi dolores magni deleniti. Nesciunt eum alias eos nesciunt nesciunt.

Ut necessitatibus non molestiae ut. Nisi maiores id possimus. Qui nemo laborum quos. Porro velit facilis quaerat aliquid a occaecati facere. Expedita sit nulla magni.

Quia quis neque eos voluptatem. Quis officia modi sit sequi. Suscipit officia dolores tempora et modi nulla.

Distinctio id nobis qui officia eligendi. Quis soluta deserunt veritatis eligendi. Sed est rerum vel saepe amet rem aperiam. A ut ab id quo qui.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 07 97.9%
  • Guggenheim Partners 01 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”